FDA Pressed To Finalize Mifepristone REMS Update, Add Miscarriage Use

A trio of Senate Democrats, including Sen. Elizabeth Warren (D-MA), is pressing FDA to quickly finalize updates to the risk-mitigation strategy for mifepristone that would make the medication abortion drug more accessible in the wake of the Supreme Court’s reversal of Roe v. Wade , and to also approve the drug for miscarriage procedures. The move comes as a duo of House and Senate lawmakers push legislation to codify the updates into law. At issue is a series of risk...